These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10297156)

  • 1. Magnifying the impact of clinical practice by automated drug reviews.
    Jinks M; Hirschman JL
    Drug Intell Clin Pharm; 1978 Aug; 12(8):470-4. PubMed ID: 10297156
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of an organized drug data base in determining contributions to the quality and efficiency of Medicaid programs.
    Roden DR; Kennard LH
    Drug Inf J; 1975; 9(2-3):131-7. PubMed ID: 10297122
    [No Abstract]   [Full Text] [Related]  

  • 4. Perspectives. Drug utilization review: apocalypse when?
    Ault A
    Faulkner Grays Med Health; 1992 Feb; 46(8):suppl 4 p.. PubMed ID: 10116064
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Watching the monitors: "PAID" prescriptions, fiscal intermediaries and drug-utilization review.
    Morgan JP
    N Engl J Med; 1977 Feb; 296(5):251-6. PubMed ID: 318733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 8. The ripple effects of a restrictive Medicaid formulary.
    Grabowski H
    Am J Manag Care; 2003 Oct; 9(10):648-9. PubMed ID: 14572174
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy to benefit from new Medicaid agreement.
    Martin S
    Am Pharm; 1990 Dec; NS30(12):25-6. PubMed ID: 2125807
    [No Abstract]   [Full Text] [Related]  

  • 11. Insurance issues and new treatments.
    Neels K
    J Am Dent Assoc; 1994 Jan; 125 Suppl():45S-53S. PubMed ID: 8294675
    [No Abstract]   [Full Text] [Related]  

  • 12. Who bears the burden of Medicaid drug copayment policies?
    Stuart B; Zacker C
    Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of computers in pharmacy in the year 2000.
    McEvilla JD; Gainor Lewis MC
    Drug Intell Clin Pharm; 1975 Aug; 9(8):439-46. PubMed ID: 10237365
    [No Abstract]   [Full Text] [Related]  

  • 14. H2 receptor antagonist usage in Missouri Medicaid recipients.
    Douglas KC; Dykstra AM; Fitzpatrick W; Lowrey L; Prosser TR; Rush DR; Stelmach WJ
    Mo Med; 1988 Dec; 85(12):779-80. PubMed ID: 2907095
    [No Abstract]   [Full Text] [Related]  

  • 15. Automated review of medical practice in the Medicaid program: benefits for providers.
    MacKay C
    J Medicaid Manage; 1977; 1(2):23-8. PubMed ID: 10297484
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy services and managed care: TPAs, PPOs and DUM (drug utilization management).
    Curtiss FR
    Empl Benefits J; 1987 Dec; 12(4):32-6. PubMed ID: 10284848
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 19. APhA announces national DUR program.
    Martin S; Menighan TE
    Am Pharm; 1990 Sep; NS30(9):29-31. PubMed ID: 2220560
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A; Masia N
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.